Latest News

Next-Generation Test Shows Sensitivity/Specificity in Pancreatic Cancer
Next-Generation Test Shows Sensitivity/Specificity in Pancreatic Cancer

March 26th 2025

The blood test showed consistent, strong results in high-risk subgroups such as those with familial history, pancreatic cysts, or diabetes.

Nivolumab-based therapies showed improved efficacy vs chemotherapy in hypermutated and Epstein-Barr virus–positive gastroesophageal tumors.
Various Mechanisms May Inform Nivolumab Use in Gastroesophageal Cancer

March 23rd 2025

Atezolizumab After Chemoradiotherapy Elicits Promising Responses in ESCC
Atezolizumab After Chemoradiotherapy Elicits Promising Responses in ESCC

March 22nd 2025

Evaluation of the 1-year overall survival data in the phase 3 ARES trial assessing MaaT013 in GVHD is expected to occur Q4 2025.
DSMB Confirms MaaT013 Efficacy/Benefit in GI-aGvHD

March 20th 2025

FDA Approves Pembrolizumab/Chemo in First-Line Gastric/GEJ Adenocarcinoma
FDA Approves Pembrolizumab/Chemo in First-Line Gastric/GEJ Adenocarcinoma

March 19th 2025

Video Series
Video Interviews
Podcasts
The approval of sotorasib plus panitumumab is a “welcome step” in KRAS G12C-mutated colorectal cancer, according to Marwan G. Fakih, MD.
Kelley A. Rone, DNP, RN, AGNP-c, provides perspective on approaching end-of-life conversations with patients with GI cancers.
Experts discuss findings related to gastrointestinal cancer outcomes as well as treatment inequalities presented at the 2024 SSO Annual Meeting.
Jun Gong, MD, and Daneng Li, MD, spoke about trials they feel can impact the gastrointestinal space during a CancerNetwork® X Space.
Experts from University of California, Los Angeles Health and Mayo Clinic discuss key data presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in the gynecologic and gastrointestinal cancer spaces and how they may impact patient care.
Oncology Peer Review On-The-Go: Tanios Bekaii-Saab, MD, and Colleagues Discuss GOZILA Platform for CRC
Oncology Peer Review On-The-Go: Tanios Bekaii-Saab, MD, Talks COLOMATE Platform in CRC With Experts
Oncology Peer Review On-The-Go

More News